Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COLL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
COLL
Collegium Pharmaceutical, Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
COLL
Collegium Pharmaceutical, Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
COLL
Collegium Pharmaceutical, Inc
Change
25.18
▲
+6.36%
· post 25.18
Mkt cap
$735.6M
Revenue
$216M
Q3 FY26
Revenue
$781M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
COLL
Collegium Pharmaceutical, Inc
vs
LLY
ELI Lilly & Co
25.18
▲
+6.36%
post 25.18
Price
1,371.32
▼
−3.29%
post 1,363.77
$735.6M
Mkt cap
$1.2T
Q3 FY26
$216M
Revenue
$24.4B
Q3 FY26
FY25
$781M
Revenue
$65.2B
FY25
Change
Change
COLL
25.18
▲
+6.36%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only COLL
2
—
Hikma Pharmaceuticals USA
unlisted
supplier
—
Grünenthal
unlisted
supplier
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›